SEP
PFE icon

Signature Equity Partners’s Pfizer PFE Stock Holding History

Signature Equity Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.8K Sell
907
-336
-27% -$8.79K 0.01% 624
2026
Q1 		$34.9K Buy
1,243
+341
+38% +$9.08K 0.02% 506
2025
Q4 		$22.5K Buy
+902
New +$22.7K 0.01% 606

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Signature Equity Partners's PFE Position: Q2 2026 in Review

Signature Equity Partners reduced its Pfizer (PFE) stake by 27% in Q2 2026, selling an estimated $8.79K and leaving 907 shares worth $21.8K. The position accounts for 0.01% of the portfolio, ranked #624.

Signature Equity Partners first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $34.9K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Signature Equity Partners held 907 shares of Pfizer worth $21.8K as of Q2 2026.
  • Signature Equity Partners sold 336 Pfizer shares in Q2 2026, an estimated $8.79K.
  • Pfizer made up 0.01% of Signature Equity Partners's portfolio in Q2 2026, its #624 holding.
  • Signature Equity Partners first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Pfizer position peaked at $34.9K in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.